CBL mutations in myeloproliferative neoplasms are also found in the gene's proline-rich domain and in patients with the V617FJAK2.
about
Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders: an analysis of 636 cases.JAK2 mutants (e.g., JAK2V617F) and their importance as drug targets in myeloproliferative neoplasmsMutation profiling of 19 candidate genes in acute myeloid leukemia suggests significance of DNMT3A mutationsHematopoietic stem cells, progenitor cells and leukemic stem cells in adult myeloproliferative neoplasms.Structural Determinants of the Gain-of-Function Phenotype of Human Leukemia-associated Mutant CBL Oncogene.Management of myelofibrosis: JAK inhibition and beyond.
P2860
CBL mutations in myeloproliferative neoplasms are also found in the gene's proline-rich domain and in patients with the V617FJAK2.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
CBL mutations in myeloprolifer ...... n patients with the V617FJAK2.
@en
CBL mutations in myeloprolifer ...... n patients with the V617FJAK2.
@nl
type
label
CBL mutations in myeloprolifer ...... n patients with the V617FJAK2.
@en
CBL mutations in myeloprolifer ...... n patients with the V617FJAK2.
@nl
prefLabel
CBL mutations in myeloprolifer ...... n patients with the V617FJAK2.
@en
CBL mutations in myeloprolifer ...... n patients with the V617FJAK2.
@nl
P2093
P2860
P50
P1433
P1476
CBL mutations in myeloprolifer ...... n patients with the V617FJAK2.
@en
P2093
Cristina Hurtado
Cristina Ormazábal
Ignacio Erquiaga
Ion Cristobal
Marina García-Delgado
Paula Aranaz
P2860
P304
P356
10.3324/HAEMATOL.2011.052605
P577
2012-02-07T00:00:00Z